001     153782
005     20240229123049.0
024 7 _ |a 10.1007/s00103-020-03102-1
|2 doi
024 7 _ |a pmid:32078705
|2 pmid
024 7 _ |a 1436-9990
|2 ISSN
024 7 _ |a 1437-1588
|2 ISSN
024 7 _ |a altmetric:76606148
|2 altmetric
037 _ _ |a DKFZ-2020-00448
041 _ _ |a ger
082 _ _ |a 610
100 1 _ |a Karrasch, Stefan
|b 0
245 _ _ |a [Lung function in the German National Cohort: methods and initial results].
260 _ _ |a Heidelberg
|c 2020
|b Springer
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1636705270_5418
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2020 Mar;63(3):322-331
520 _ _ |a A nationwide assessment of the respiratory status on the basis of standardized lung function measurements has so far not been available in Germany. The present work describes the lung function tests in the German National Cohort (GNC) and presents initial results based on the GNC Midterm Baseline Dataset.The assessment of lung function in the GNC comprised spirometry (level 1) and the determination of exhaled nitric oxide (FeNO, level 2). Our quality assurance concept included regular training of lung function test procedures at various GNC sites, interim evaluations of test quality, as well as regular calibration/measurement checks of test equipment. For spirometry, we established a stepwise procedure for offline quality control based on raw flow volume curves.In the present dataset (n = 101,734), spirometry was available for 86,893 study participants and FeNO was available for 15,228 participants. The average (±SD) FEV1 Z score (according to GLI 2012) was -0.321 ± 1.047, the FVC Z score was -0.153 ± 0.941, and the FEV1/FVC Z score was -0.337 ± 0.901. The difference in FEV1/FVC between current smokers and never-smokers increased with age. The average FeNO was 14.2 ÷ 2.0 ppb. Current smoking reduced FeNO levels by 43%, whereas respiratory allergy increased FeNO levels by 16% in nonsmokers.The results of spirometry and the FeNO measurements are in the expected range with regard to their distributions and correlates. The GNC provides a valuable basis for future investigations of respiratory health and its determinants as well as research into the prevention of respiratory diseases in Germany.
536 _ _ |a 313 - Cancer risk factors and prevention (POF3-313)
|0 G:(DE-HGF)POF3-313
|c POF3-313
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Peters, Annette
|b 1
700 1 _ |a Meisinger, Christa
|b 2
700 1 _ |a Ferland, Maike
|b 3
700 1 _ |a Jaeschke, Lina
|b 4
700 1 _ |a Pischon, Tobias
|b 5
700 1 _ |a Fricke, Julia
|b 6
700 1 _ |a Keil, Thomas
|b 7
700 1 _ |a Gastell, Sylvia
|b 8
700 1 _ |a Schulze, Matthias
|b 9
700 1 _ |a Brandes, Mirko
|b 10
700 1 _ |a Günther, Kathrin
|b 11
700 1 _ |a Kuß, Oliver
|b 12
700 1 _ |a Schikowski, Tamara
|b 13
700 1 _ |a Emmel, Carina
|b 14
700 1 _ |a Jöckel, Karl-Heinz
|b 15
700 1 _ |a Michels, Karin B
|b 16
700 1 _ |a Franzke, Claus-Werner
|b 17
700 1 _ |a Langer, Susan
|b 18
700 1 _ |a Mikolajczyk, Rafael
|b 19
700 1 _ |a Jagodzinski, Annika
|b 20
700 1 _ |a Becher, Heiko
|b 21
700 1 _ |a Castell, Stefanie
|b 22
700 1 _ |a Kemmling, Yvonne
|b 23
700 1 _ |a Waniek, Sabina
|b 24
700 1 _ |a Lieb, Wolfgang
|b 25
700 1 _ |a Wirkner, Kerstin
|b 26
700 1 _ |a Loeffler, Markus
|b 27
700 1 _ |a Greiser, Karin Halina
|0 P:(DE-He78)e0ac0d57cdb66d87f2d95ae5f6178c1b
|b 28
|u dkfz
700 1 _ |a Kaaks, Rudolf
|0 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
|b 29
|u dkfz
700 1 _ |a Legath, Nicole
|b 30
700 1 _ |a Berger, Klaus
|b 31
700 1 _ |a Schipf, Sabine
|b 32
700 1 _ |a Hoffmann, Wolfgang
|b 33
700 1 _ |a Sedlmeier, Anja
|b 34
700 1 _ |a Leitzmann, Michael
|b 35
700 1 _ |a Brenner, Hermann
|0 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
|b 36
|u dkfz
700 1 _ |a Holleczek, Bernd
|b 37
700 1 _ |a Schulz, Holger
|b 38
773 _ _ |a 10.1007/s00103-020-03102-1
|0 PERI:(DE-600)1470303-8
|n 3
|p 322-331
|t Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
|v 63
|y 2020
|x 1437-1588
909 C O |p VDB
|o oai:inrepo02.dkfz.de:153782
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 28
|6 P:(DE-He78)e0ac0d57cdb66d87f2d95ae5f6178c1b
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 29
|6 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 36
|6 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-313
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Cancer risk factors and prevention
|x 0
914 1 _ |y 2020
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b BUNDESGESUNDHEITSBLA : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 0
920 1 _ |0 I:(DE-He78)C070-20160331
|k C070
|l C070 Klinische Epidemiologie und Alternf.
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a I:(DE-He78)C070-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21